Announcements Trials

Conditions

Gastrointestinal 1Gynecologic 1Other 1

Drug Classes

Anti-PD-1 13PARP inhibitor 6Platinum agent 5Taxane 5Anti-FOLR1 ADC 2Anti-TF ADC 2Anti-VEGFR 2Anti-HER2 ADC 1Anti-PD-L1 1BRAF inhibitor 1Glucocorticoid receptor antagonist 1MEK inhibitor 1Multi-ingredient 1Multikinase inhibitor 1RET inhibitor 1ROS1 inhibitor 1TRK inhibitor 1Topoisomerase I inhibitor 1
Topoisomerase I inhibitor × Gynecologic × Clear all

1 Announcement

2006-06-14

FDA approves topotecan hydrochloride (hycamtin) in combination with cisplatin for the treatment of Stage IVB recurrent or persistent carcinoma of the cervix

Drugs
Hycamtin (topotecan hydrochloride) · Topoisomerase I inhibitor, cisplatin · Platinum agent
Condition
Gynecologic
Data powered by HemOnc (CC BY 4.0) Colophon âš¡